During hospitalization at the Department of Nuclear Medicine and Endocrine Oncology, the pathognomonic for the diagnosis of insulinoma, hypoglycemia (1.97 mmol/L) with inadequately high levels of insulin (24 uIU/mL) and peptide (3.14 ng/mL), was found. This evidence concerns the gene INS and pancreatic insulinoma.